High-risk human papillomavirus infection and overexpression of p53 protein in squamous cell carcinoma of the esophagus from Japan

Diseases of the Esophagus

Volumn 11, Issue 3, 1998, Pages 162-167

  Takahashi, A ^a   Ogoshi, S ^a   Ono, H ^a   Ishikawa, T ^a   Toki, T ^a   Ohmori, N ^a   Iwasa, M ^a   Iwasa, Y ^a   Furihata, M ^a   Ohtsuki, Y ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS DNA;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOT HYBRIDIZATION; ESOPHAGUS CARCINOMA; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; JAPAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCREENING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS;

EID: 0031737520     PISSN: 11208694     EISSN: None     Source Type: Journal    
DOI: 10.1093/dote/11.3.162     Document Type: Article

References (18)

1. Chang F, Syrjänen S, Wang L, Syrjänen K. Infectious agents in the etiology of esophageal cancer. Gastroenterology 1992; 103: 1136-1148.
2. Durst M, Gissman L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Nat Acad Sci (Wash) 1983; 80: 3812-3815.
3. Yee C, Krishinan-Hewlett I, Baker C C et al. Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Amer J Pathol 1985; 119: 361-366.
4. Zaki S R, Judd R, Coffield L M et al. Human papillomavirus infection and anal carcinoma. Am J Pathol 1992; 140: 1345-1355.
5. Anwar K, Nakakuki K, Nakai H, Inuzuka M. ras gene mutations and HPV infection are common in human laryngeal carcinoma. Int J Cancer 1993; 53: 22-28.
6. Furihata M, Ohtsuki Y, Ogoshi S et al. Prognostic significance of human papillomavirus genomes (type-16, -18) and aberrant expression of p53 protein in human esophageal cancer. Int J Cancer 1993; 54: 226-230.
7. Toh Y, Kuwano H, Tanaka S et al. Detection of human papillomavirus DNA in esophageal carcinoma in Japan by polymerase chain reaction. Cancer 1992; 70: 2234-2238.
8. Furihata M, Ohtsuki Y, Ogoshi S et al. The detection of either human papillomavirus genomes (type 16 and 18) or overexpressed p53 protein in esophageal cancer patients from Kochi, Japan. Am J Gastroenterol 1993; 88: 471-472.
9. Chang F, Syrjänen S, Shen Q, Ji H. Human papillomavirus (HPV) DNA in esophageal precancer lesions and squamous cell carcinomas from China. Int J Cancer 1990; 45: 21-25.
10. Benamouzig R, Pigot F, Quiroga G et al. Human papillomavirus infection in esophageal squamous-cell carcinoma in Western countries. Int J Cancer 1992; 50: 549-552.
11. Hille J J, Markowitz S, Margolius K A, Isaacson C. Human papillomavirus and carcinoma of the oesophagus. N Engl J Med 1985; 312: 1707.
12. Mori M, Shimono R, Inoue T et al. Papillomavirus and esophageal cancer in the Japanese and Chinese. Amer J Gastroenterol 1989; 84: 1126-1127.
13. Scheffner M, Werness B, Huibregtse J M et al. The E6 oncoprotein encoded by human papillomavirus type 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
14. Werness B A, Levine A J, Howley P M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990; 248: 76-79.
15. De Villiers E M. Heterogeneity of the human papillomavirus group. J Virol 1989; 63: 4898-4903.
16. Furihata M, Inoue K, Ohtsuki Y et al. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Research 1993; 53: 4823-4827.
17. Ohta M, Casanova H, Mizuno K et al. Epidemiologic background and changes in patients infected with human papillomavirus. Acta Obst Gynaec Jpn 1991; 43: 479-482.
18. Saiki R K, Scharf S, Faloona F. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985; 230: 1350-1354.